Adam S. Grossman - Feb 25, 2024 Form 4 Insider Report for ADMA BIOLOGICS, INC. (ADMA)

Signature
/s/ Adam S. Grossman, by Brian Lenz as Attorney-in-fact
Stock symbol
ADMA
Transactions as of
Feb 25, 2024
Transactions value $
-$118,124
Form type
4
Date filed
2/27/2024, 09:00 PM
Previous filing
Jan 5, 2024
Next filing
Feb 28, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADMA Common Stock Tax liability -$118K -22.5K -1.01% $5.26 2.21M Feb 25, 2024 Direct F1, F2, F3
holding ADMA Common Stock 1.14M Feb 25, 2024 See Footnote F4
holding ADMA Common Stock 581K Feb 25, 2024 See Footnote F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes, as of the transaction date, (i) 573,695 RSUs granted on March 6, 2023 that will vest quarterly on the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (ii) 225,000 unvested RSUs granted on March 7, 2022 that will vest quarterly on the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; (iii) 226,875 unvested Time-Based RSUs granted on September 29, 2021, subject to time based vesting conditions (the "Time-Based RSUs") which will vest in eight (8) equal quarterly installments over a period of two years following December 31, 2022, becoming fully vested on December 31, 2024 and that will be settled into common stock upon vesting, subject to the reporting person's continued employment on the applicable vesting date;
F2 (continued from footnote 1) (iv) 45,785 unvested RSUs granted on February 25, 2021, of which 45,788 unvested RSUs will vest quarterly on each anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date, will be settled into common stock upon vesting;
F3 (continued from footnote 2) (v) 25,000 unvested RSUs granted on February 28, 2020, which vest quarterly on each anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and will be settled into common stock upon vesting; and (vi) 1,112,498 shares of common stock owned by the reporting person, which reflects prior purchases and the prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes.
F4 These shares are owned by Areth, LLC ("Areth"). The reporting person is a control person of Areth.
F5 These shares are owned by Hariden, LLC ("Hariden"). The reporting person is the managing member of Hariden.